Healthcare Triangle, Inc. (HCTI)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023
Total Revenue3,139,000$3,489,000$3,558,000$3,704,000$2,190,000$2,413,000$2,984,000$4,109,000$7,060,000$7,779,000$8,526,000$9,838,000$
QoQ%(10.03%)(1.94%)(3.94%)69.13%(9.24%)(19.14%)(27.38%)(41.80%)(9.24%)(8.76%)(13.34%)
YoY%43.33%44.59%19.24%(9.86%)(68.98%)(68.98%)(65.00%)(58.23%)
Cost Of Revenue2,691,000$2,871,000$3,064,000$3,375,000$1,934,000$1,691,000$2,086,000$3,095,000$5,530,000$6,072,000$6,579,000$8,245,000$
Gross Profit165,000,000$0$0$1,070,000,000$0$0$0$1,070,000,000$1,530,000$1,707,000$1,947,000$1,593,000$
Gross Margin5,256.45%.00%.00%28,887.69%.00%.00%.00%26,040.40%21.67%21.94%22.84%16.19%
Operating Expenses4,891,000$3,209,000$1,853,000$1,727,000$754,000$1,889,000$2,276,000$2,727,000$2,897,000$3,231,000$3,542,000$4,802,000$
Operating Income(4,443,000$)(2,591,000$)(1,359,000$)(1,398,000$)(498,000$)(1,167,000$)(1,378,000$)(1,713,000$)(1,367,000$)(1,524,000$)(1,595,000$)(3,209,000$)
Operating Margin(141.54%)(74.26%)(38.20%)(37.74%)(22.74%)(48.36%)(46.18%)(41.69%)(19.36%)(19.59%)(18.71%)(32.62%)
Interest Income
Interest Expenses100,000$32,000$21,000$413,000$853,000$(80,000$)(131,000$)(149,000$)305,000$(415,000$)(186,000$)(62,000$)
Income Before Tax(4,503,000$)(1,906,000$)(1,368,000$)(1,700,000$)(1,344,000$)(1,247,000$)(1,509,000$)(1,862,000$)(1,672,000$)(1,939,000$)(1,781,000$)(3,259,000$)
Tax Expenses4,000$2,000$1,000$5,000$7,000$4,000$5,000$19,000$
Net Income(4,503,000$)(1,906,000$)(1,368,000$)(1,700,000$)(1,348,000$)(1,249,000$)(1,510,000$)(1,862,000$)(1,679,000$)(1,943,000$)(1,786,000$)(3,278,000$)
Profit Margin(143.45%)(54.63%)(38.45%)(45.90%)(61.55%)(51.76%)(50.60%)(45.32%)(23.78%)(24.98%)(20.95%)(33.32%)
TTM(68.23%)(48.85%)(47.75%)(51.43%)(51.04%)(38.03%)(31.89%)(26.46%)(26.16%)
Earnings to Minority(8,958,000$)(3,812,000$)(2,696,000$)(2,498,000$)
Earnings to Common Shareholders4,455,000$1,906,000$(1,368,000$)(1,700,000$)1,348,000$1,249,000$(1,510,000$)(1,862,000$)(1,679,000$)(1,943,000$)(1,786,000$)(3,278,000$)
QoQ%133.74%239.33%19.53%(226.11%)7.93%182.72%18.90%(10.90%)13.59%(8.79%)45.52%
YoY%230.49%52.60%9.40%8.70%180.29%164.28%15.45%43.20%
Earnings Per Share, Basic(0.27$)0.43$(0.58$)(0.17$)(0.30$)54.89$(70.72$)(0.42$)(0.42$)(0.45$)(0.42$)(0.79$)
Earnings Per Share, Diluted(0.27$)0.43$(0.58$)(0.17$)(0.30$)54.89$(70.72$)(0.42$)(0.42$)(0.45$)(0.42$)(0.79$)
Unlevered FCF Per Share, Basic0.42$(0.34$)(1.12$)(0.56$)0.18$31.42$(43.79$)(0.01$)0.15$0.00$(0.27$)(0.39$)
Unlevered FCF Per Share, Diluted0.42$(0.34$)(1.12$)(0.56$)0.18$31.42$(43.79$)(0.01$)0.15$0.00$(0.27$)(0.39$)
Average Shares, Basic-16,383,4984,443,7842,343,3859,843,821-4,497,94022,75621,3514,455,2453,992,2694,277,8634,273,1424,173,286
Average Shares, Diluted-16,383,4984,443,7842,343,3859,843,821-4,497,94022,75621,3514,455,2453,992,2694,277,8634,273,1424,173,286
EBIT(4,403,000$)(1,874,000$)(1,347,000$)(1,287,000$)(491,000$)(1,327,000$)(1,640,000$)(2,011,000$)(1,367,000$)(2,354,000$)(1,967,000$)(3,321,000$)
EBITDA(3,773,000$)(1,811,000$)(1,347,000$)(1,275,000$)(636,000$)(984,000$)(1,106,000$)(1,475,000$)(2,189,000$)(1,640,000$)(1,165,000$)(2,447,000$)